[1]Patent:WO2007/104696,2007,A1.Locationinpatent:Page/Pagecolumn61-62
[2]JournalofMedicinalChemistry,1981,vol.24,p.481-490
[3]JournalofMedicinalChemistry,1993,vol.36,p.4239-4249
[4]JournalofMedicinalChemistry,2007,vol.50,p.595-598
29270-30-2
40061-54-9
85259-19-4
5445-25-0
41024-33-3
77583-73-4
220616-68-2 | 2,6-Dibromo-4-hydroxypyridine | AA00BICU | MFCD13185517
270912-79-3 | 2-((5-Bromopyrimidin-2-yl)oxy)acetic acid | AA00BIKF | MFCD09753920
20942-70-5 | 5-tert-Butyl-2-iodophenol | AA00BIUZ | MFCD15527200
252357-43-0 | (R,S)-Boc-2-amino-4,4-difluoro-butyric acid | AA00BJ7K | MFCD18761982
24155-34-8 | 2-(1H-Imidazol-1-yl)-1-phenylethanone | AA00BJMA | MFCD00107975
209860-89-9 | Tafluprost ethyl ester | AA00BJVX
207400-12-2 | 2-Benzothiazoleacetonitrile,6-ethoxy-(9CI) | AA00BLSZ | MFCD14584942
31150-99-9 | 2-Chloro-4-nitrobenzenesulfonamide | AA00BNR6 | MFCD00454356
2286-33-1 | Ethyl 2-cyano-3-(4-nitrophenyl)acrylate | AA00BQAO | MFCD00024795
21639-39-4 | 2H-1,2,3-Benzothiadiazine 1,1-dioxide | AA00BSLU | MFCD01928776